
IDEX Biometrics ASA specializes in developing, manufacturing, and selling advanced fingerprint identification systems. The company's reach extends across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. Their biometric technologies are primarily integrated into secure contactless financial payment systems, access control solutions, various types of smart cards, and specialized card devices for storing digital currencies. IDEX Biometrics ASA principally serves companies that produce smart cards for financial transactions and the expanding market for biometric payment cards. Founded in 1996, the firm's main office is located in Oslo, Norway.
IDEX Biometrics ASA trades as IDEX.OL on OSL. The company is classified in Technology / Semiconductors and reports in NOK.
The current profile places the business in Semiconductors. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
IDEX Biometrics ASA can be compared against peers such as 5th Planet Games A/S, Huddly AS, Huddlestock Fintech AS, NEXT Biometrics Group ASA, River Tech p.l.c., Techstep ASA.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $601.46M, beta of 1.11, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
IDEX.OL currently shows total debt of N/A and beta of 1.11. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.idexbiometrics.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.